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Abstract- A simple, precise and cost effective colorometric method have been developed for the 
estimation of Rantidine hydrochloride in its pharmaceutical formulations. RNH shows λmax at 
520.0 nm. The drug follows the Beer-Lambert’s law. The method validated by following the 
analytical performance parameters suggested by the International Conference on Harmonization. 
All validation parameters were within the acceptable range. The developed methods were 
successfully applied to estimate the amount of RNH in pharmaceutical dosage forms. 





1), is a histamine H2-blocker commonly 
used in clinical practice for the treatment of 
duodenal ulcers.  
This RNH has been determined by high-
performanc liquid chromatography, capillary 
electrophoresis, spectrofluorimetry, near 
infrared spectrophotometry, proton magnetic 
resonance spectroscopy, voltammetry, 
differential polarography, the techniques are 
tedious, time consuming, and involve 
expensive instrumental set-up. 
In the present work, an effort has been made 
to develop simple, sensitive, selective and 
cost-effective methods utilizing the thio 
group of the molecule. 
 
2 Experimental 
2.1 Standard  
Aliquots of standard reduced RNH solution 
(0.25-2.5 mL; 200 µg mL−1) were delivered 
into a series of10 mL calibrated flasks. The 
solution was acidified by adding 0.5 mL of 1 
M HCl and the total volume was adjusted to 
4 mL by adding water. Then, 1 mL each of 
0.4% iodate and 6% sodium chloride 
solutions were added in succession, the 
contents were mixed well and the flasks 
were set aside for 20 min with occasional 
shaking. Finally, 2 mL each of 0.01% 2,4- 
dichlorofluorescein solution and 
monochloro acetic acid reagent (pH 4.35) 
were added to each flask and the volume 
was diluted to the mark with water. The 
absorbance of the coloured solution was 
measured at 520 nm against a reagent blank.  
 
2.2 Sample  
Twenty tablets were weighed accurately and 
ground into a fine powder. A portion of the 
powder equivalent to 200 mg of RNH was 
weighed accurately into a 100 mL 
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volumetric flask, 60 mL of water, 5 mL of 5 
M HCl and 500 mg of zinc dust were added 
and shaken thoroughly for about 30 min. 
Then, the volume was made up to the mark 
with water, mixed well and filtered using 
Whatman No. 41 filter paper. A suitable 
aliquot was used for analysis by titrimetry. 
The solution was appropriately diluted with 
water to get 200 µg mL−1 solution and 
analysed spectrophotometrically using a 
convenient volume. In the case of injectable 
products, known volumes equivalent to 200 
mg of RNH were measured accurately into a 
100 mL beaker, 60 mL of water, 5mL of 5 
M HCl and 500 mg of zinc dust were added 
and stirred for 30 min. The insoluble mass 
was filtered on a Whatman No. 41 filter 
paper, washedwith water and the filtrate plus 
washings were diluted to 100 mL with water 
in a calibrated flask.The solution (2 mg 
mL−1) was subjected to analysis by  
spectrophotometry as described above after 
appropriate dilution. 
 
3. Result and discussion 
In colorometry, the drug was treated with a 
large unmeasured excess of iodate and the 
iodine formed was determined by an 
auxiliary reaction with dichlorofluorescein. 
In both the methods, reduction of nitro 
group of the molecule with zinc/HCl was the 
first step. Unreduced RNH was found to 
give erratic results. 
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